...
首页> 外文期刊>Maternal and child health journal >Comparison between once weekly, twice weekly, and daily oral iron therapy in Jordanian children suffering from iron deficiency anemia.
【24h】

Comparison between once weekly, twice weekly, and daily oral iron therapy in Jordanian children suffering from iron deficiency anemia.

机译:患有缺铁性贫血的约旦儿童每周一次,每周两次和每日口服铁疗法的比较。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The efficacy of daily versus twice weekly and once weekly oral iron therapy was analyzed to optimize a protocol for treatment of IDM among Jordanian children. One hundred and forty-eight children aged between 6 and 60?months with Hb estimate less than 11?gm/dl were screened. They were randomly divided into three regimens of oral iron therapy for a period of 12?weeks; a group was supplemented with a single weekly dose of iron; a second group received two doses weekly; and a third group had a daily dose of iron. Hb was assayed 3 and 12?weeks after therapy, while ferritin was assayed after 12?weeks of treatment. A significant rise in Hb concentration was observed which was most significant 12?weeks after treatment. Iron supplementation after 3?weeks was similar in all treated groups, and no significant difference in Hb concentration among the three groups was noticed. By the end of the third week, the anemia had respectively resolved by 18, 11.8 and 23.4% in the daily, twice weekly, and once weekly groups. On the other hand, the percentage of recovery of anemia respectively was 78, 90.2 and 74.5% at the end of 12?weeks of iron therapy. Hb recovery percentage was comparable in the three treated groups, and no significant difference was reported between them either at 3 or at 12?weeks of therapy. Ferritin levels in the daily and twice weekly treated groups were similar after 12?weeks of iron therapy and were significantly higher than the ferritin levels of weekly treated group. Although the anemia in the three treated groups was resolved after 3 and 12?weeks of oral iron therapy, we conclude that the regimen of two doses per week is the most effective in resolving anemia with less cost and fewer side effects.
机译:分析了每日铁水疗法与每周两次和每周一次口服铁疗法的疗效,以优化约旦儿童IDM的治疗方案。筛选了168名年龄在6至60个月之间且Hb估计低于11μg/ dl的儿童。他们被随机分为三种口服铁剂治疗方案,为期12周。一组每周补充一次铁剂;第二组每周接受两剂;第三组每天服用铁。在治疗后3周和12周测定血红蛋白,在治疗12周后测定铁蛋白。治疗后12周,Hb浓度显着升高。所有治疗组3周后的补铁情况相似,三组之间的Hb浓度无显着差异。到第三周末,每天,每周两次和每周一次贫血分别减少了18%,11.8%和23.4%。另一方面,在用铁疗法治疗12周后,贫血恢复率分别为78%,90.2%和74.5%。在三个治疗组中,血红蛋白恢复百分率相当,并且在治疗第3周或第12周时,两者之间无明显差异。铁治疗12周后,每日和每周两次治疗组的铁蛋白水平相似,并且显着高于每周治疗组的铁蛋白水平。尽管三个治疗组的贫血在口服铁剂治疗3周和12周后得以缓解,但我们得出的结论是,每周两次剂量的方案是解决贫血最有效的方法,其成本更低且副作用更少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号